Fisher Scientific Acquires 93.6 Percent of Perbio Science

Fisher Scientific International Inc. announced that it has acquired 93.6 percent of Perbio Science AB, a $250 million manufacturer and supplier of technologies, products and services to the life-science and biotechnology industries. All conditions of the tender offer have been satisfied, including the 90 percent minimum acceptance requirement.

At the close of the extended acceptance period, 93.6 percent of the total number of shares and votes of Perbio, calculated on a fully diluted basis, were tendered into Fisher's final offer of SEK 155 per share and SEK 106 per warrant. For shareholders who have accepted the final offer, cash settlement is expected to take place on Sept. 8, at which time Fisher will assume operational responsibility for Perbio.

"We are pleased that the holders of an overwhelming majority of Perbio's shares have accepted our offer," said Paul M. Montrone, chairman and chief executive officer of Fisher Scientific. "We will move quickly to complete the transaction and leverage Perbio's manufacturing strengths in the life-science market with Fisher's global sales, marketing and distribution network to accelerate growth."

To provide an opportunity for the remaining shareholders to accept the offer, the acceptance period for the offer relating to the shares in Perbio is further extended until 4 p.m. Central European Time (CET) on Sept. 19, without any remaining conditions. As a result, the right to withdraw acceptances does not apply during the extended acceptance period. For shares tendered during the extended acceptance period, cash settlement is expected to occur on or about Sept. 26.

Quelle: Fisher Scientific